Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutation screening of the APOA5 gene in subjects with coronary artery disease.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research - 1 Oct 2012

Soufi Muhidien, Sattler Alexander M, Kurt Bilgen, Schaefer Juergen R

Abstract excerpt

OBJECTIVE: Hyperlipidemia is a risk factor for coronary artery disease (CAD). Apolipoprotein A5 (APOA5) is a member of the apolipoprotein APOA1/C3/A4/A5 gene cluster and a major determinant of plasma triglyceride levels in the population. Various studies have identified a number of common (APOA5...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lipoproteins
Share to Apolipoprotein A-V
Share to Apolipoproteins A

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Coronary Artery Disease

Share to DNA Mutational Analysis

Share to Gene Frequency

Share to Genetic Predisposition to Disease

Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 22914599
DOI: 10.2310/JIM.0b013e3182686918

Genes

APOA5
CAD
APOA1

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22914599-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutation screening of the APOA5 gene in subjects with coronary artery disease.PMID 22914599Read ↗

Effects of polymorphisms in APOA5 on the plasma levels of triglycerides and risk of coronary heart disease in Jilin, northeast China: a case-control study.Semantic proximity Read ↗

A functional variant in APOA5/A4/C3/A1 gene cluster contributes to elevated triglycerides and severity of CAD by interfering with microRNA 3201 binding efficiency.Semantic proximity Read ↗

Apolipoprotein A5 gene variants and the risk of coronary heart disease: a case‑control study and meta‑analysis.Semantic proximity Read ↗

Genetics: Mutations in APOA5 or LDLR increase risk of myocardial infarction.Semantic proximity Read ↗

Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men.Semantic proximity Read ↗

Association between sequence variant of c.553 G > T in the apolipoprotein A5 gene and metabolic syndrome, insulin resistance, and carotid atherosclerosis.Semantic proximity Read ↗

Apolipoprotein A5 polymorphisms and risk of coronary artery disease: a meta-analysis.Semantic proximity Read ↗

Positive Association between APOA5 rs662799 Polymorphism and Coronary Heart Disease: A Case-Control Study and Meta-Analysis.Semantic proximity Read ↗

Genome-wide association study identifies a missense variant at APOA5 for coronary artery disease in Multi-Ethnic Cohorts from Southeast Asia.Semantic proximity Read ↗

Association of rs662799 in APOA5 with CAD in Chinese Han population.Semantic proximity Read ↗

APOA5 Ala315>Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levels.Semantic proximity Read ↗

SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5/A4/C3/A1 locus on chromosome 11q23 in the Northern Irish population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.